XWELL Inc (XWEL)
1.745
+0.02
(+1.36%)
USD |
NASDAQ |
Nov 04, 16:00
1.80
+0.05
(+3.14%)
Pre-Market: 20:00
XWELL Enterprise Value: -0.7802M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -0.7802M |
| November 01, 2024 | -0.9037M |
| October 31, 2024 | -0.5448M |
| October 30, 2024 | -0.3345M |
| October 29, 2024 | -0.6236M |
| October 28, 2024 | -0.4396M |
| October 25, 2024 | -0.7445M |
| October 24, 2024 | -0.6499M |
| October 23, 2024 | -0.755M |
| October 22, 2024 | -0.3871M |
| October 21, 2024 | -0.6236M |
| October 18, 2024 | -0.3871M |
| October 17, 2024 | -0.755M |
| October 16, 2024 | -0.2231M |
| October 15, 2024 | -0.1768M |
| October 14, 2024 | -0.4922M |
| October 11, 2024 | -0.4396M |
| October 10, 2024 | -0.5364M |
| October 09, 2024 | -0.5879M |
| October 08, 2024 | -1.228M |
| October 07, 2024 | -0.9127M |
| October 04, 2024 | -0.8601M |
| October 03, 2024 | -1.018M |
| October 02, 2024 | -0.6762M |
| October 01, 2024 | -0.8601M |
| Date | Value |
|---|---|
| September 30, 2024 | -0.8601M |
| September 27, 2024 | -0.5448M |
| September 26, 2024 | -1.281M |
| September 25, 2024 | -1.281M |
| September 24, 2024 | -0.939M |
| September 23, 2024 | -0.755M |
| September 20, 2024 | -0.2294M |
| September 19, 2024 | 0.0071M |
| September 18, 2024 | -0.0717M |
| September 17, 2024 | 0.1385M |
| September 16, 2024 | -1.281M |
| September 13, 2024 | -1.491M |
| September 12, 2024 | -1.438M |
| September 11, 2024 | -1.386M |
| September 10, 2024 | -1.018M |
| September 09, 2024 | -0.8076M |
| September 06, 2024 | -0.9652M |
| September 05, 2024 | -0.6499M |
| September 04, 2024 | -0.4901M |
| September 03, 2024 | -0.1768M |
| August 30, 2024 | 0.0339M |
| August 29, 2024 | 0.5064M |
| August 28, 2024 | -0.3871M |
| August 27, 2024 | -0.2294M |
| August 26, 2024 | -0.4922M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.11M
Minimum
Sep 28 2023
296.15M
Maximum
Jun 22 2020
35.45M
Average
16.59M
Median
Nov 26 2019
Enterprise Value Benchmarks
| Fonar Corp | 28.39M |
| ProPhase Labs Inc | 53.59M |
| Applied DNA Sciences Inc | -8.715M |
| Veracyte Inc | 2.454B |
| OncoCyte Corp | 39.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.996M |
| Revenue (Quarterly) | 9.282M |
| Total Expenses (Quarterly) | 11.16M |
| EPS Diluted (Quarterly) | -0.48 |
| Gross Profit Margin (Quarterly) | 33.17% |
| Profit Margin (Quarterly) | -21.50% |
| Earnings Yield | -288.2% |
| Normalized Earnings Yield | -173.26 |